Myocardial high-energy phosphates and function under different postischemic conditions. A study in a paracorporeal rat heart model.

J Hultman; G Ronquist

doi:10.1159/000128410

Home/Archive/PubMed

PubMed · 6745308

Myocardial high-energy phosphates and function under different postischemic conditions. A study in a paracorporeal rat heart model.

J Hultman·G Ronquist

View original source ↗Export metadata ↓

Abstract

Infusion of phosphoenolpyruvate together with adenosine triphosphate early during reperfusion after ischemia increased the energy content and the left ventricular isovolumic performance in a paracorporeal rat heart model. Excised hearts were subjected to 15 min of complete global ischemia at 37 degrees C before reperfusion. During reperfusion they were either nonworking (empty-beating) or working (performing left ventricular isovolumic work) between 20 and 40 min of reperfusion before freeze-clamping. Early during reperfusion the excised hearts were either supplemented with 144 mumol phosphoenolpyruvate and 0.67 mumol adenosine triphosphate or nonsupplemented (plain saline) administered in a pulsatile arterial blood flow. The supplemented nonworking group showed significantly higher creatine phosphate and adenosine triphosphate contents compared to the nonsupplemented group. However, under postischemic working conditions there were no significant differences in high-energy phosphates between the supplemented and the nonsupplemented groups in spite of significantly better left ventricular isovolumic performance in the supplemented group. Concomitantly the efflux of creatine kinase isoenzyme MB indicating cellular damage was significantly less for this group. The data presented here favor the view of a possible compartmentalized adenosine triphosphate pool with a high metabolic turnover close to the plasma membrane.

Explore related subjects

Adenosine Diphosphate Adenosine Triphosphate Animals Coronary Circulation Creatine Kinase Extracorporeal Circulation Isoenzymes Male Myocardial Contraction Myocardial Infarction Myocardium Oxygen Consumption Perfusion Phosphocreatine Phosphoenolpyruvate Rats Rats, Inbred Strains Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J Hultman, G Ronquist. 1984. Myocardial high-energy phosphates and function under different postischemic conditions. A study in a paracorporeal rat heart model.. https://doi.org/10.1159/000128410

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder.

PURPOSE: Diphthamide is a post-translationally modified histidine essential for messenger RNA translation and ribosomal protein synthesis. We present evidence for DPH5 as a novel cause of embryonic lethality and profound neurodevelopmental delays (NDDs). METHODS: Molecular testing was performed using exome or genome sequencing. A targeted Dph5 knockin mouse (C57BL/6Ncrl-Dph5em1Mbp/Mmucd) was created for a DPH5 p.His260Arg homozygous variant identified in 1 family. Adenosine diphosphate-ribosylation assays in DPH5-knockout human and yeast cells and in silico modeling were performed for the identified DPH5 potential pathogenic variants. RESULTS: DPH5 variants p.His260Arg (homozygous), p.Asn110Ser and p.Arg207Ter (heterozygous), and p.Asn174LysfsTer10 (homozygous) were identified in 3 unrelated families with distinct overlapping craniofacial features, profound NDDs, multisystem abnormalities, and miscarriages. Dph5 p.His260Arg homozygous knockin was embryonically lethal with only 1 subviable mouse exhibiting impaired growth, craniofacial dysmorphology, and multisystem dysfunction recapitulating the human phenotype. Adenosine diphosphate-ribosylation assays showed absent to decreased function in DPH5-knockout human and yeast cells. In silico modeling of the variants showed altered DPH5 structure and disruption of its interaction with eEF2. CONCLUSION: We provide strong clinical, biochemical, and functional evidence for DPH5 as a novel cause of embryonic lethality or profound NDDs with multisystem involvement and expand diphthamide-deficiency syndromes and ribosomopathies.

Adenosine Diphosphate↗

PubMed2007

A mobile tryptophan is the intrinsic charge transfer donor in a flavoenzyme essential for nikkomycin antibiotic biosynthesis.

The flavoenzyme nikD is required for the biosynthesis of nikkomycin antibiotics. NikD exhibits an unusual long wavelength absorption band attributed to a charge transfer complex of FAD with an unknown charge transfer donor. NikD crystals contain an endogenous active site ligand. At least four different compounds are detected in nikD extracts, including variable amounts of two ADP derivatives that bind to the enzyme's dinucleotide binding motif in competition with FAD, picolinate (0.07 mol/mol of nikD) and an unknown picolinate-like compound. Picolinate, the product of the physiological catalytic reaction, matches the properties deduced for the active site ligand in nikD crystals. The charge transfer band is eliminated upon mixing nikD with excess picolinate but not by a reversible unfolding procedure that removes the picolinate-like compound, ruling out both compounds as the intrinsic charge transfer donor. Mutation of Trp355 to Phe eliminates the charge transfer band, accompanied by a 30-fold decrease in substrate binding affinity. The results provide definitive evidence for Trp355 as the intrinsic charge transfer donor. The indole ring of Trp355 is coplanar with or perpendicular to the flavin ring in "open" or "closed" crystalline forms of nikD, respectively. Importantly, a coplanar configuration is required for charge transfer interaction. Absorption in the long wavelength region therefore constitutes a valuable probe for monitoring conformational changes in solution that are likely to be important in nikD catalysis.

Adenosine Diphosphate↗

PubMed2007

Bioinformatic discovery of novel bioactive peptides.

Short synthetic oligopeptides based on regions of human proteins that encompass functional motifs are versatile reagents for understanding protein signaling and interactions. They can either mimic or inhibit the parent protein's activity and have been used in drug development. Peptide studies typically either derive peptides from a single identified protein or (at the other extreme) screen random combinatorial peptides, often without knowledge of the signaling pathways targeted. Our objective was to determine whether rational bioinformatic design of oligopeptides specifically targeted to potentially signaling-rich juxtamembrane regions could identify modulators of human platelet function. High-throughput in vitro platelet function assays of palmitylated cell-permeable oligopeptides corresponding to these regions identified many agonists and antagonists of platelet function. Many bioactive peptides were from adhesion molecules, including a specific CD226-derived inhibitor of inside-out platelet signaling. Systematic screens of this nature are highly efficient tools for discovering short signaling motifs in molecular signaling pathways.

Adenosine Diphosphate↗